1. Gadolinium-based contrast agents safe to use, says US FDA

   News item 03 June 2017 Pages: 1 - 1

2. HSA in Singapore reports local safety signals for 2016

   News item 03 June 2017 Pages: 2 - 2

3. HSA: new recommendations for domperidone use

   News item 03 June 2017 Pages: 3 - 3

4. Ingenol mebutate information updated in Australia

   News item 03 June 2017 Pages: 4 - 4

5. New version of EudraVigilance to be launched

   News item 03 June 2017 Pages: 5 - 5

6. Singapore's HSA analyses AE reports across 2016

   News item 03 June 2017 Pages: 6 - 6

7. Testosterone replacement therapy: risk of ATE/VTE

   News item 03 June 2017 Pages: 7 - 7

8. TGA reinforces interactions warning with Viekira-PAK products

   News item 03 June 2017 Pages: 8 - 8

9. International Society of Pharmacovigilance: new phase

   News item 03 June 2017 Pages: 9 - 9

10. Adverse drug reactions with medicines of unknown identity

    Clinical study 03 June 2017 Pages: 10 - 10

11. Interferon-β: signals of potential adverse events

    Clinical study 03 June 2017 Pages: 11 - 11

12. Metformin: no apparent association with cognition

    Clinical study 03 June 2017 Pages: 12 - 12

13. Acenocoumarol

    Case report 03 June 2017 Pages: 13 - 13

14. Acetazolamide

    Case report 03 June 2017 Pages: 14 - 14

15. Acetylcholine/ergometrine

    Case report 03 June 2017 Pages: 15 - 15

16. Adalimumab

    Case report 03 June 2017 Pages: 16 - 16

17. Adalimumab

    Case report 03 June 2017 Pages: 17 - 17

18. Adalimumab

    Case report 03 June 2017 Pages: 18 - 18

19. Adalimumab/etanercept/infliximab

    Case report 03 June 2017 Pages: 19 - 19

20. Adalimumab/infliximab

    Case report 03 June 2017 Pages: 20 - 20

21. Aflibercept

    Case report 03 June 2017 Pages: 21 - 21

22. Aflibercept/bevacizumab

    Case report 03 June 2017 Pages: 22 - 22

23. Alemtuzumab

    Case report 03 June 2017 Pages: 23 - 23

24. Alendronic acid/zoledronic acid

    Case report 03 June 2017 Pages: 24 - 24

25. Alitretinoin/prednisone

    Case report 03 June 2017 Pages: 25 - 25

26. Alprazolam/hydroxyzine

    Case report 03 June 2017 Pages: 26 - 26

27. Alprazolam/methadone/venlafaxine

    Case report 03 June 2017 Pages: 27 - 27

28. Alteplase

    Case report 03 June 2017 Pages: 28 - 28

29. Alteplase

    Case report 03 June 2017 Pages: 29 - 29

30. Amiodarone

    Case report 03 June 2017 Pages: 30 - 30

31. Amiodarone

    Case report 03 June 2017 Pages: 31 - 31

32. Amiodarone

    Case report 03 June 2017 Pages: 32 - 32

33. Amiodarone

    Case report 03 June 2017 Pages: 33 - 33

34. Amiodarone/thiamazole/mexiletine

    Case report 03 June 2017 Pages: 34 - 34

35. Amiodarone/zolpidem

    Case report 03 June 2017 Pages: 35 - 35

36. Amoxicillin

    Case report 03 June 2017 Pages: 36 - 36

37. Amoxicillin/clavulanic acid

    Case report 03 June 2017 Pages: 37 - 37

38. Amphotericin B

    Case report 03 June 2017 Pages: 38 - 38

39. Amphotericin-b-liposomal/flucytosine/itraconazole

    Case report 03 June 2017 Pages: 39 - 39

40. Antibacterials/aspirin

    Case report 03 June 2017 Pages: 40 - 40

41. Antibacterials/immunosuppressants

    Case report 03 June 2017 Pages: 41 - 41

42. Antihypertensives

    Case report 03 June 2017 Pages: 42 - 42

43. Antineoplastics

    Case report 03 June 2017 Pages: 43 - 43

44. Antineoplastics

    Case report 03 June 2017 Pages: 44 - 44

45. Antineoplastics

    Case report 03 June 2017 Pages: 45 - 45

46. Antiretrovirals

    Case report 03 June 2017 Pages: 46 - 46

47. Antiretrovirals

    Case report 03 June 2017 Pages: 47 - 47

48. Antithymocyte globulin/busulfan/cyclophosphamide

    Case report 03 June 2017 Pages: 48 - 48

49. Antitubercals

    Case report 03 June 2017 Pages: 49 - 49

50. Antituberculars

    Case report 03 June 2017 Pages: 50 - 50